Crossmark

Dystrophin is a tumor suppressor in human cancers with myogenic programs

Crossref DOI link: https://doi.org/10.1038/ng.2974

Published Online: 2014-05-04

Published Print: 2014-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Yuexiang

Marino-Enriquez, Adrian

Bennett, Richard R

Zhu, Meijun

Shen, Yiping

Eilers, Grant

Lee, Jen-Chieh

Henze, Joern

Fletcher, Benjamin S

Gu, Zhizhan

Fox, Edward A

Antonescu, Cristina R

Fletcher, Christopher D M

Guo, Xiangqian

Raut, Chandrajit P

Demetri, George D

van de Rijn, Matt

Ordog, Tamas

Kunkel, Louis M

Fletcher, Jonathan A
License Information

Text and Data Mining valid from 2014-05-04
More Information

Article History

Received: 11 January 2013

Accepted: 9 April 2014

First Online: 4 May 2014

Competing interests

: The authors declare no competing financial interests.